Subscribe to stay up to date with the latest Sonrai content.
PRESS RELEASE 16/02/2023
Sonrai Analytics, a UK global precision medicine innovator in AI, and United Arab Emirates (UAE) based Alliance Care Technologies (ACT), a developer of innovative solutions in digital healthcare, have announced a strategic partnership to bring transformational AI solutions to enhance cancer detection and biomarker discovery to the UAE market.
The Preferred Partnership agreement signed at the Arab Health Congress will give UAE researchers, and clinicians access to AI-supported clinical systems to assist in the accelerated detection of cancerous tumours and improve patient outcomes. Through this partnership, ACT can access Sonrai’s proprietary AI technology and expertise to bring this precision oncology capability to more oncologists, hospital systems and other medical providers in the UAE.
Sonrai’s pedigree in building AI assets for regulatory approval has been deployed in high-level programmes with Roche and the NHS. Through ACT, leading healthcare organisations will have access to Sonrai’s comprehensive AI suite and cloud services, including the potential to co-develop algorithms that could become AI biomarker tests for healthcare organisations.
Speaking at Arab Health, Founder-CEO of Sonrai Analytics, Dr Darragh McArt said: “We are delighted to have this partnership in place to expand our market opportunity to new territories and to introduce our AI data analytics platform and algorithms to key individuals in the care pathway to improve patient outcomes. ACT has a fantastic understanding of the area in which Sonrai operates, and I look forward to a successful relationship.”
Michele Tarnow, CEO, Alliance Care Technologies said: “UAE's diverse population makes it uniquely situated for universal population health research. Sonrai provides the ideal platform for collaborative research across omics medicine, biotech and pharma. Alliance Care Technologies is excited to announce Sonrai's arrival in the Gulf Cooperation Council (GCC) and the opportunity to support the region's growth in global health.”
Northern Ireland's dynamic Life and Health Sciences sector employs over 18,000 people and generates over £1.3 billion in revenues. This region of the UK is home to a wealth of innovative companies, as well as internationally recognised universities, such as Queen's University Belfast and Ulster University, both renowned for world-leading research in biomedical sciences. Today, researchers are at the forefront of convergent technology in the areas of health data analytics, machine learning and diagnostics.
Fahd Asif, Senior Business Development Manager at Invest Northern Ireland, said, "This agreement will play a vital role in achieving the region's vision of reducing cancer mortality via early detection and screening. We were delighted to facilitate the introduction between both parties and this partnership arises as part of our efforts in the Middle East to promote Northern Ireland's capability in Life and Health Sciences. As Northern Ireland's Economic Development Agency, we continue to support Sonrai Analytics in achieving its growth, which has the potential to transform and progress the preventative healthcare system in the region."
ENDS
For UK & Ireland media enquiries contact:
Chris Martin
Head of Marketing
Sonrai Analytics
P: 07517428996
E: c.martin@sonraianalytics.com
NOTES TO EDITOR
About Sonrai Analytics
Sonrai Analytics was founded in 2018 by Dr Darragh McArt and Dr Deva Senevirathne as a technology start-up within Healthcare and Precision Medicine domains. Through its AI data analytics platform and services, Sonrai streamlines precision medicine organisations' ability to identify, validate and productise novel biomarkers, diagnostics, or clinical algorithms with life-saving potential.
The company recently announced a seed plus funding round of £2.175 million to accelerate the global adoption of its technology. This added investment will help Sonrai reach more companies globally to translate precision medicine’s complex multi-omics data into real insights leading to better-personalised treatments for patients.
Sonrai Analytics has successfully placed its platform with key healthcare businesses across the EU and the US and is entering further key partnerships that will scale operations commercially.
For additional information, please visit: sonraianalytics.com
About Alliance Care Technologies
Driven by a vision for equitable, universal access to value-based healthcare, Alliance Care Technologies develops and deploys advanced technology and artificial intelligence solutions that solve today's most pressing healthcare challenges. We work with physicians, patients, researchers, industry leaders, and entrepreneurs to design individualised solutions that enhance the patient experience, streamline administrative processes, manage costs, and ultimately improve healthcare outcomes across the healthcare continuum.
For additional information, please visit: alliancecaretech.com
About Invest Northern Ireland
As Northern Ireland's business development agency, Invest NI's role is to grow the local economy. We do this by helping new and existing businesses to compete internationally, and by attracting new investment to Northern Ireland. We are part of the Department for the Economy and provide strong government support for business by effectively delivering the Government’s economic development strategies.
For additional information, please visit: investni.com
